Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Robinson

Maternal & Fetal Medicine Mount Pleasant, SC Medical Doctor

NPI 1750353355 CMS profile 982726

1716 W Canning Dr, Mount Pleasant, SC 29466

Open in the dashboard

General payments

$121,149

86 records reported · program years 2019–2025

Research payments

$30,264

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Robinson of Mount Pleasant, SC is reported in the CMS Open Payments database as having received $121,149 across 86 general payments and $30,264 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Maternal & Fetal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $29,528 13
2025 Research $4,935 1
2024 General $12,207 9
2024 Research $16,364 4
2023 General $12,204 11
2023 Research $8,965 4
2022 General $9,399 11
2021 General $9,942 7
2020 General $18,338 7
2019 General $29,531 28

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Robinson
  • Maternal & Fetal Medicine median
  • Middle half of Maternal & Fetal Medicine
  • National median

In program year 2025, general payments to Christopher Robinson were reported at $29,528. Among 891 Maternal & Fetal Medicine profiles paid that year, the median was $56 and the middle half received between $25 and $146.

Show as a table
Year Christopher Robinson Maternal & Fetal Medicine median Middle half National median
2019 $29,531 $70 $23–$148 $163
2020 $18,338 $51 $18–$141 $114
2021 $9,942 $43 $20–$137 $132
2022 $9,399 $48 $22–$145 $149
2023 $12,204 $53 $24–$150 $160
2024 $12,207 $68 $25–$159 $164
2025 $29,528 $56 $25–$146 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AMAG Pharmaceuticals, Inc. $22,343 7 payments
  2. Seqirus USA Inc $14,906 8 payments
  3. UCB, Inc. $12,123 17 payments
  4. Medicines360 $11,570 3 payments
  5. AbbVie, Inc. $9,465 6 payments
  6. Teva Pharmaceuticals USA, Inc. $7,734 3 payments
  7. Pfizer Inc. $7,650 2 payments
  8. Grifols USA, LLC $7,314 9 payments
  9. Janssen Scientific Affairs, LLC $6,545 7 payments
  10. Novo Nordisk AS $4,975 6 payments
  11. Other $16,525 18 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $110,248 55 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,355 4 payments
  3. Travel and Lodging $2,025 12 payments
  4. Gift $2,000 1 payment
  5. Food and Beverage $520 14 payments
Products named General payments · program years 2019–2025
  1. Liletta $11,570 3 payments
  2. NURTEC ODT $10,400 3 payments
  3. Cimzia $8,763 16 payments
  4. AJOVY $7,734 3 payments
  5. FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) $7,731 3 payments
  6. Thrombate III $7,314 9 payments
  7. SKYRIZI Immunology $5,092 3 payments
  8. Sunosi $4,750 1 payment
  9. SKYRIZI Immunology $3,371 1 payment
  10. AFLURIA QUADRIVALENT $2,100 2 payments
  11. Other $2,315 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Celgene Corporation $13,615 2 payments
  2. Teva Pharmaceuticals USA, Inc. $10,399 4 payments
  3. Harmony Biosciences LLC $4,000 2 payments
  4. Sumitomo Pharma America, Inc. $2,250 1 payment

Records

95 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Maternal & Fetal Medicine in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record